A forum for researchers, students and applicants in the field of cyclodextrin technology
Amgen (NASDAQ:AMGN) recently announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA)
The 6th European Cyclodextrin Conference will be held in Santiago de Compostela between October 2–4, 2019. The following deadlines have
Researchers from Kumamoto University (Hidetoshi Arima, Keiichi Motoyama, Taishi Higashi) filed an international patent application on a novel synthesis of
Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra), a biotechnology company devoted to development of next-generation medicines to improve the lives of
Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company discovering, developing and commercializing novel antibiotics to treat serious bacterial infections, delivered eight
Amgen (NASDAQ:AMGN) recently announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA)
The increasing interest in organic agriculture, the growing resistance of pests against traditional pesticides and the demand for insecticides and
CD was immobilized on the surface of zeolite particles by using crosslinking with citric, succinic or adipic acid to improve
Abzena company developed a series of antibody drug conjugates (ADCs) using IgG1, IgG2, IgG4, mAbs, and other antibodies modified with
Since the last review in the Cyclodextrin News summarizing the anti aging effects of retinol (Vitamin A) and its derivatives,
The 6th European Cyclodextrin Conference will be held in Santiago de Compostela between October 2–4, 2019. The following deadlines have
The idea of producing cyclodextrin-enabled edible film coating on food items to improve the shelf life goes back to 1983
A new open-access book on host-guest polymer complexes edited by A E. Tonelli, G. Narayanan and A. Gurarslan was published
